Pfizer Deutschland is involved in the development and production of pharmaceuticals, including innovative medicines and vaccines. The company is known for its contributions to healthcare, particularly in the creation of treatments such as antibiotics, vitamins, and COVID-19 vaccines.

Pfizer Deutschland

Pharmaceutical Manufacturing

Pfizer CentreOne

Pfizer Medical

Anacor Pharmaceuticals

Biotechnology

Bamboo Therapeutics, Inc. a wholly owned subsidiary of Pfizer Inc.

Pfizer | 6,054,564 followers on LinkedIn. We’re celebrating 175 years of daring scientific innovation—and we’re not done yet. Every day, we’re channeling our passion and resources into delivering innovative therapies that change the face of healthcare. Let’s outdo yesterday.

Candidate Experience - Recruitment for Pfizer Research and Development

Ted Clark

Talent Acquisition at Pfizer

Karen Michelson

Manager , Pfizer Pharmaceuticals

Timothy L. Anderson

Pfizer

Is the Medicine in Your Medicine Cabinet Safe? Unfortunately, there is a troubling lack of knowledge about counterfeits among U.S. healthcare providers. Therein lies opportunity in empowering health care providers and patients

Understanding proteins helps unlock new insights, develop innovative treatments, and drive scientific progress. To introduce our new #explainer series, which breaks down some of the scientific concepts central to our work at Pfizer, we’re exploring what proteins are and how they play a vital role in countless daily processes within our bodies. #Proteins #Innovation

Pfizer has been recognized in the top 25% of Forbes ' inaugural list of America's Best Employers for Tech Workers, where we are one of just four companies spotlighted in the Drug and Biotechnology category. Pfizer’s inclusion on this prestigious list is a testament to our dynamic and supportive culture, where every colleague has the opportunity to grow, excel, and make a meaningful impact. https://lnkd.in/gjmBJCbd

We’re supporting The Leukemia & Lymphoma Society as they work to define #BloodCancer and redefine what’s possible after diagnosis. Together, in partnership with the blood cancer community, we remain dedicated to making meaningful change to create a world where people with blood cancer live longer and better lives.

Today in a late-breaking presentation at ESMO - European Society for Medical Oncology 2024, we unveil new Phase 2 data in cancer cachexia, a life-threatening wasting condition with no FDA-approved treatments. Learn more about our #cachexia research: https://lnkd.in/eNS2kcB3 #Cachexia #ESMO24

We’re pleased to partner with the International Myeloma Foundation to raise awareness of the impact of #MultipleMyeloma . Our long-standing relationships with the community are imperative in understanding and supporting the unique needs of patients as we work to deliver breakthroughs in #BloodCancer and #kNOwMyeloma .

We're proud to partner with multidisciplinary stakeholders to support the IHI-SYNTHIA project – an initiative led by the Innovative Health Initiative aiming to revolutionize the field of personalized medicine by harnessing the power of synthetic data to improve health outcomes, including in cancer and #Hematology . #SYNTHIA

“You can’t do anything if you don’t have colleagues that are talented, that are motivated, that are driven by purpose.” A great message from my colleague Chris Boshoff, MD, PhD, FMedSci , and one with which I completely agree. Our Pfizer Oncology team exemplifies hard work, dedication, and above all, passion. We’re working tirelessly to develop a new generation of potential breakthroughs across cancers and tumor types that brings new hope to patients—because we’re united by the shared vision of a world where people with cancer live better and longer lives.

Albert Bourla

As part of Pfizer’s ambition to achieve the Net Zero Standard and RE100, we’re proud to partner with Vesper Energy and others to help generate new solar energy. Learn more below 👇

Really great event today in our NYC office celebrating Pride month.

DNSSEC

Font Awesome

Mobile Non Scaleable Content

Apple Mobile Web App Capable

ASP.NET

IIS 10

Common Name Invalid

CrUX Top 10m

ASP.NET 4.0

Typekit

Owner

Alan Lanterman

Chief

Alvey Roger

CSO Label & Systems Specialist

Amber Potter

Sr. Principal Scient

Amin Kamel

Chief Financial Officer

Anna White

Senior Vice President and Chief Scientific Officer Bacterial Vaccines and Hospital

Annaliesa Anderson

Asset Process Owner

Anthony Barricelli

Director/Epm Solution Owner

Ashwin Pulimamidi

President

Bayron Lopez

Regional President North America Inflammation & Immunology

Beatriz Faro

New York Companies With More Than 50 Employees (Top 10K)

Pharmaceutical Companies With More Than 50 Employees (Top 10K)

Northeastern US Companies With More Than 1000 Employees

Pharmaceutical Companies With More Than 100 Employees

Pfizer Deutschland is a researcher, developer, and provider of medicines and vaccines.

New York

United States

North America

Germany

Europe

Austria

Latvia

Italy

Switzerland

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Nov 14, 2024 2:04 PM	a743c736
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Nov 14, 2024 2:04 PM	6193ccdd
crunchbase trigger	general	Nov 14, 2024 2:04 PM	be5ca3fc
crunchbase profile	general	Nov 15, 2024 4:13 AM	e2ef1e52
li profile	general	Nov 14, 2024 2:04 PM	a1cd80af
translate crunchbase fundingrounds	general	Nov 15, 2024 7:02 AM	c99a1189
peers	general	Nov 14, 2024 2:04 PM	b4fadec0
news basic	general	Nov 14, 2024 2:04 PM	a4524684
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

PFIZ

DE:PFIZER

Pfizer Deutschland